Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Jonathan D. Edgeworth"'
Autor:
Luke B Snell, Adela Alcolea-Medina, Themoula Charalampous, Christopher Alder, Tom G S Williams, Flavia Flaviani, Rahul Batra, Prijay Bakrania, Rajeni Thangarajah, Stuart J D Neil, Claire van Nispen tot Pannerden, Alina Botgros, Emma Aarons, Samuel T Douthwaite, Jonathan D Edgeworth, Gaia Nebbia
Publikováno v:
Clinical Infectious Diseases. 76:1125-1128
The management of coronavirus disease 2019 has become more complex due to the expansion of available therapies. The presence of severe acute respiratory syndrome coronavirus 2 variants and mutations further complicates treatment due to their differin
Autor:
Ashwini Kurshan, Luke B Snell, Lucie Prior, Jerry C H Tam, Carl Graham, Rajeni Thangarajah, Jonathan D Edgeworth, Gaia Nebbia, Katie J Doores
Publikováno v:
Oxford Open Immunology. 4
Neutralizing monoclonal antibodies (mAbs) targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike glycoprotein have been developed for the treatment of COVID-19. Whilst antibody therapy has been shown to reduce the risk of COVID-
Autor:
Peter Roberts, Domenico Merante, David M. Livermore, Andrew Jones, Paul Jones, Mari Ariyasu, Richard Beale, Seema Vithlani, Jonathan D. Edgeworth, Christopher Young, Sanjay Patel, Tsutae Den Nagata, Duncan Wyncoll
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Serious infections such as endocarditis due to extremely drug-resistance gram-negative bacteria are an increasing challenge. Here, we present successful adjunctive use of cefiderocol for a patient with persistently bacteremic healthcare-associated na
Autor:
K A Brown, G. Mahalingam, Tracey Mare, Sion M. Lewis, Richard Beale, Jonathan D. Edgeworth, Martin Stacey, David F. Treacher, C. S Brown
Publikováno v:
Clinical and Experimental Immunology. 182:184-194
Summary There is a need for cellular biomarkers to differentiate patients with sepsis from those with the non-infectious systemic inflammatory response syndrome (SIRS). In this double-blind study we determined whether the expression of known (CD11a/b
Publikováno v:
Open Forum Infectious Diseases
Background Methicillin-Resistant Staphylococcus aureus (MRSA) and C. difficile infection have reduced across the UK National Health Service in the last decade following implementation of an infection control campaign. The national impact on hospital-
Publikováno v:
Open Forum Infectious Diseases
Background Despite the escalating level of concern regarding the spread of Carbapenem resistant and Extended spectrum β-lactamase (ESBL) producing Enterobacteriaceae (CR-E and ESBL-E), little is still known about their dissemination within household
Autor:
Olga Tosas, Eleonora Dyakova, Rahul Batra, Jonathan A. Otter, Alex Natale, Jonathan D. Edgeworth
Publikováno v:
Open Forum Infectious Diseases
Background Individual risk factors such as antibiotic use and foreign travel are typically associated with ESBL-producing Enterobacteriaceae (ESBL-E) carriage. Few studies have evaluated variations in community demographics or social and material dep
Publikováno v:
Open Forum Infectious Diseases. 4:S139-S139
Publikováno v:
Open Forum Infectious Diseases. 4:S151-S151
Autor:
Barry Cookson, Ben S. Cooper, Olga Tosas Auguet, Jonathan D. Edgeworth, Julie V. Robotham, Sarah R Deeny, Colin J. Worby
Publikováno v:
Clinical Infectious Diseases. 62:1193.2-1194